$2.45T
Total marketcap
$75.5B
Total volume
BTC 50.71%     ETH 15.57%
Dominance

Cryo-Cell CCEL Stock

7.21 USD {{ price }} -0.867579% {{change_pct}}%
Market Cap
59.75M USD
LOW - HIGH [24H]
7.05 - 7.35 USD
VOLUME [24H]
5.87K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.14 USD

Cryo-Cell Price Chart

Cryo-Cell CCEL Financial and Trading Overview

Cryo-Cell stock price 7.21 USD
Previous Close 5.34 USD
Open 6.03 USD
Bid 2.3 USD x 800
Ask 0 USD x 800
Day's Range 5.41 - 6.03 USD
52 Week Range 2.69 - 8.12 USD
Volume 7.8K USD
Avg. Volume 9.1K USD
Market Cap 49.82M USD
Beta (5Y Monthly) 0.323591
PE Ratio (TTM) 20
EPS (TTM) -1.14 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date September 1, 2022
1y Target Est 10 USD

CCEL Valuation Measures

Enterprise Value 53.14M USD
Trailing P/E 20
Forward P/E 40
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6122122
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.72
Enterprise Value/EBITDA 8.715

Trading Information

Cryo-Cell Stock Price History

Beta (5Y Monthly) 0.323591
52-Week Change 2.04%
S&P500 52-Week Change 20.43%
52 Week High 8.12 USD
52 Week Low 2.69 USD
50-Day Moving Average 4.64 USD
200-Day Moving Average 4.69 USD

CCEL Share Statistics

Avg. Volume (3 month) 9.1K USD
Avg. Daily Volume (10-Days) 10.1K USD
Shares Outstanding 8.3M
Float 4.48M
Short Ratio 2.5
% Held by Insiders 47.58%
% Held by Institutions 12.58%
Shares Short 17.36K
Short % of Float 0.30%
Short % of Shares Outstanding 0.20%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends November 30, 2022
Most Recent Quarter (mrq) February 28, 2023
Next Fiscal Year End November 30, 2023

Profitability

Profit Margin 8.75%
Operating Margin (ttm) 14.96%
Gross Margin 71.66%
EBITDA Margin 19.73%

Management Effectiveness

Return on Assets (ttm) 4.77%
Return on Equity (ttm) 151.87%

Income Statement

Revenue (ttm) 30.9M USD
Revenue Per Share (ttm) 3.66 USD
Quarterly Revenue Growth (yoy) 7.79%
Gross Profit (ttm) 21.54M USD
EBITDA 6.1M USD
Net Income Avi to Common (ttm) 2.71M USD
Diluted EPS (ttm) 0.3
Quarterly Earnings Growth (yoy) -7.79%

Balance Sheet

Total Cash (mrq) 2.21M USD
Total Cash Per Share (mrq) 0.27 USD
Total Debt (mrq) 11.01M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.562
Book Value Per Share (mrq) -0.081

Cash Flow Statement

Operating Cash Flow (ttm) 8.71M USD
Levered Free Cash Flow (ttm) -6808467 USD

Profile of Cryo-Cell

Country United States
State FL
City Oldsmar
Address 700 Brooker Creek Boulevard
ZIP 34677
Phone 813 749 2100
Website https://www.cryo-cell.com
Industry Medical Care Facilities
Sector(s) Healthcare
Full Time Employees 80

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Q&A For Cryo-Cell Stock

What is a current CCEL stock price?

Cryo-Cell CCEL stock price today per share is 7.21 USD.

How to purchase Cryo-Cell stock?

You can buy CCEL shares on the NYSE American exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cryo-Cell?

The stock symbol or ticker of Cryo-Cell is CCEL.

Which industry does the Cryo-Cell company belong to?

The Cryo-Cell industry is Medical Care Facilities.

How many shares does Cryo-Cell have in circulation?

The max supply of Cryo-Cell shares is 8.29M.

What is Cryo-Cell Price to Earnings Ratio (PE Ratio)?

Cryo-Cell PE Ratio is now.

What was Cryo-Cell earnings per share over the trailing 12 months (TTM)?

Cryo-Cell EPS is -1.14 USD over the trailing 12 months.

Which sector does the Cryo-Cell company belong to?

The Cryo-Cell sector is Healthcare.